BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹15 Cr | ₹31 Cr | ₹19 Cr | ₹19 Cr | ₹12 Cr |
What is the latest Net Current Assets ratio of BAL PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹15 Cr |
| Mar2024 | ₹31 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹19 Cr |
| Mar2021 | ₹12 Cr |
How is Net Current Assets of BAL PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹15 Cr | -50.58 | |
| Mar2024 | ₹31 Cr | 65.25 | |
| Mar2023 | ₹19 Cr | -0.55 | |
| Mar2022 | ₹19 Cr | 62.96 | |
| Mar2021 | ₹12 Cr | - | |
Compare Net Current Assets of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹95.6 Cr | -9.7% | -21.9% | -21.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,647.0 Cr | 0.1% | -0.4% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹157,862.0 Cr | -1.1% | -7.1% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,846.0 Cr | 0.2% | -4.5% | 30.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,720.0 Cr | 0.2% | -4% | 6% | Stock Analytics | |
| CIPLA | ₹98,795.9 Cr | 0% | -9.1% | -18.5% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -9.7% |
-21.9% |
-21.8% |
| SENSEX | -3.5% |
-12.5% |
-6.5% |
You may also like the below Video Courses